These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4179299)

  • 21. The influence of various adjuvants on the IgM and IgG diphtheria antibodies formation in rabbits immunized with diphtheria toxoid. I. Antibody activity in the whole sera.
    Galazka A; Sporzynska Z; Aleksandrowicz J; Mierzejewska H
    Z Immunitatsforsch Exp Klin Immunol; 1971 Sep; 142(3):284-96. PubMed ID: 4256634
    [No Abstract]   [Full Text] [Related]  

  • 22. Adoptive transfer of immunologic tolerance into normal mice.
    Crowle AJ; Hu CC
    J Immunol; 1969 Dec; 103(6):1242-7. PubMed ID: 4243427
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antibody formation in the mouse by the ascites technic].
    Negro Ponzi A; Fontana G; Forni G; Savoia D
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1970; 63(1):48-59. PubMed ID: 4096980
    [No Abstract]   [Full Text] [Related]  

  • 24. [MULTIPLE SCLEROSIS-AN IMMUNOLOGICAL PROBLEM].
    TSCHABITSCHER H
    Wien Klin Wochenschr; 1963 Aug; 75():604. PubMed ID: 14054751
    [No Abstract]   [Full Text] [Related]  

  • 25. Time relationships between injection of antigen and adjuvant. V. Primary and secondary immune responses to sheep erythrocytes in mice pretreated with incomplete freund's adjuvant.
    Finger H; Emmerling P; Hof H; Plager L
    Z Immunitatsforsch Exp Klin Immunol; 1973 May; 145(3):227-41. PubMed ID: 4283266
    [No Abstract]   [Full Text] [Related]  

  • 26. ON THE MECHANISM OF ADJUVANT ACTION OF NONSPECIFIC STIMULATORS OF ANTIBODY FORMATION.
    UCHITEL IY; KHASMAN EL
    J Immunol; 1965 Apr; 94():492-7. PubMed ID: 14299020
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparative study of the adjuvant power of lipopolysaccharides of gram-negative bacteria and the corresponding lipid fractions in the mouse].
    Creach O; Gaja R; Fontanges R
    Ann Inst Pasteur (Paris); 1968 Jun; 114(6):786-95. PubMed ID: 5760430
    [No Abstract]   [Full Text] [Related]  

  • 28. Antigen adjuvants.
    White RG
    Mod Trends Immunol; 1967; 2():28-52. PubMed ID: 4871640
    [No Abstract]   [Full Text] [Related]  

  • 29. Significance of the quantitative relationships of antigen and adjuvant for the efficiency of the adjuvant.
    Tanaka A
    Int Arch Allergy Appl Immunol; 1969; 36():Suppl:310-27. PubMed ID: 4984657
    [No Abstract]   [Full Text] [Related]  

  • 30. The immunoglobulin nature of the antigen recognition site on cells mediating transplantation immunity and delayed hypersentivity.
    Mason S; Warner NL
    J Immunol; 1970 Mar; 104(3):762-5. PubMed ID: 4190976
    [No Abstract]   [Full Text] [Related]  

  • 31. Experimental modulation of the reactivity of pleural milky spots (Kampmeier's foci) by Freund's adjuvants, betamethasone and mycobacterial infection.
    Pereira Ade D; Aguas AP; Oliveira MJ; Cabral JM; Grande NR
    J Anat; 1994 Dec; 185 ( Pt 3)(Pt 3):471-9. PubMed ID: 7649783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The adjuvant action of endotoxin in thymectomized mice.
    Campbell PA; Rowlands DT; Harrington MJ; Kind PD
    J Immunol; 1966 May; 96(5):849-53. PubMed ID: 4161838
    [No Abstract]   [Full Text] [Related]  

  • 33. The comparative selectivity of adjuvants for humoral and cell-mediated immunity. I. Effect on the antibody response to bovine serum albumin and sheep red blood cells of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin.
    Bomford R
    Clin Exp Immunol; 1980 Feb; 39(2):426-34. PubMed ID: 6248282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myeloma-specific transplantation resistance: a requirement for complete Freund's adjuvant stimulation of effectors.
    Bridges SH
    J Immunol; 1978 Feb; 120(2):613-8. PubMed ID: 621397
    [No Abstract]   [Full Text] [Related]  

  • 35. Specific immune responses of dairy cattle after primary inoculation with recombinant bovine interferon-gamma as an adjuvant when vaccinating against mastitis.
    Pighetti GM; Sordillo LM
    Am J Vet Res; 1996 Jun; 57(6):819-24. PubMed ID: 8725806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Montanide adjuvants, IMS 3012 (Nanoparticle), ISA 206 and ISA 35 (Emulsion based) along with incomplete Freund's adjuvant for hyperimmunization of equines used for production of polyvalent snake antivenom.
    Waghmare A; Deopurkar RL; Salvi N; Khadilkar M; Kalolikar M; Gade SK
    Vaccine; 2009 Feb; 27(7):1067-72. PubMed ID: 19100805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant granuloma and its effect on the immune response in the gunea pig.
    Wilkinson PC
    Pathol Eur; 1966; 1(1):204-16. PubMed ID: 5989461
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunological adjuvants. VI. An acetylated mycobacterial adjuvant lacking competing antigenicity.
    Tanaka A; Ishibashi T; Sugiyama K; Takamoto M
    Z Immunitatsforsch Exp Klin Immunol; 1971 Nov; 142(4):303-17. PubMed ID: 4257657
    [No Abstract]   [Full Text] [Related]  

  • 39. On the capacity of pepsin-digested antibody to neutralize adenovirus infectivity.
    Kjellén L
    Immunology; 1965 Jun; 8(6):557-65. PubMed ID: 4158519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the adjuvant action on mineral oil and bacterial endotoxin.
    Somura Y
    Jpn J Microbiol; 1972 Jul; 16(4):307-19. PubMed ID: 4119944
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.